New Centralized Model to Include Hundreds of Research Sites Across North America
The clinical affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced the expansion of its clinical research education program – Patient Advocates for Lupus Studies (PALS) – making it available to hundreds of individuals living with lupus across North America. The expansion builds on the program’s success to date and aims to continue increasing awareness, participation, and representation in lupus clinical trials.
Launched in 2019 and designed with people living with lupus, the PALS program has shown to increase knowledge and interest in clinical trials, according to published results of its pilot study. To date, the program has reached more than 100 people with support from six biopharmaceutical companies. With this launch, the program will support three clinical trials.
To learn more about the next phase of this program, visit here.
Tags: Patient Advocates for Lupus Studies, PALS, Caroline Donovan, Kendra Latigue, lupus therapeutics